UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050714
Receipt number R000057655
Scientific Title A double-blind, randomized, parallel-group study of the effect of topical additional dexamethasone of fascia iliaca compartment block (FICB) in proximal femoral fracture surgery
Date of disclosure of the study information 2023/04/10
Last modified on 2024/05/17 12:03:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the effect of steroid addition of nerve block in hip fracture surgery

Acronym

Study of the effects of steroid-added FICB

Scientific Title

A double-blind, randomized, parallel-group study of the effect of topical additional dexamethasone of fascia iliaca compartment block (FICB) in proximal femoral fracture surgery

Scientific Title:Acronym

Study of the effects of steroid-added FICB

Region

Japan


Condition

Condition

Proximal femoral fracture

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

There are a few reports that the addition of steroids is useful in prolonging the duration of effect of peripheral nerve blocks. In addition, reports of the benefit of FICB for analgesia in proximal femoral fracture surgery have been recognized. The purpose of this study is to evaluate whether the local addition of dexamethasone is effective in prolonging the analgesic effect, especially the duration of effect, of FICB in proximal femoral fracture surgery. We further assess the side effects of topical addition of dexamethasone.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Duration from FICB administration to first as-needed analgesic administration

Key secondary outcomes

Number of doses of as-needed analgesics (within 48 hours from FICB)
Safety evaluation items:
Vital sign changes such as postoperative hypotension (within 48 hours from FICB)
Prolongation of motor block of the affected limb (within 48 hours from FICB)
Local infection (within 1 week after surgery)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

In the addition group: dexamethasone (Orgadrone Injection) 3.8mg(1ml) is added to the drug solution used for the previous FICB at our institution.

Interventions/Control_2

In the control group: FICB is performed as before.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients who will be underwent proximal femoral fracture surgery under general anesthesia combined with ultrasound-guided FICB at our facility.
2.Subjects who can make self-judgment and are voluntarily giving written informed consent.

Key exclusion criteria

1.Patients who cannot complain of pain or patients who cannot administer NSAIDs or acetaminophen
2.Patients who received NSAIDs or acetaminophen within 3 hours before entering the operating room to immediately after surgery
3.Subjects who have diabetes or prone to infections
4.Others who have been determined ineligible by principal investigator or sub-investigator

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shima
Middle name
Last name Taguchi

Organization

Shimura Hospital

Division name

Department of Anesthesiology

Zip code

7340007

Address

3-13 Funairimachi, Naka-ku, Hiroshima-City 730-0841 Japan

TEL

+818019122416

Email

yohtamam@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Shima
Middle name
Last name Taguchi

Organization

Shimura Hospital

Division name

Department of Anesthesiology

Zip code

7340007

Address

3-13 Funairimachi, Naka-ku, Hiroshima-City 730-0841 Japan

TEL

+818019122416

Homepage URL


Email

yohtamam@hiroshima-u.ac.jp


Sponsor or person

Institute

Shimura Hospital

Institute

Department

Personal name



Funding Source

Organization

Shimura Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The institutional review board of Shimura Hospital

Address

3-13 Funairimachi, Naka-ku, Hiroshima-City 730-0841 Japan

Tel

0822945151

Email

t-yossy@rc4.so-net.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

120

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 01 Month 10 Day

Date of IRB

2023 Year 01 Month 20 Day

Anticipated trial start date

2023 Year 02 Month 01 Day

Last follow-up date

2024 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 29 Day

Last modified on

2024 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057655